Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

DRI-FORM: GBNA LISTERIA MEDIUM NO. M22300

K-Number: K863820 · 1986-10-08

ApplicantGibco Laboratories Life Technologies, Inc.
Decision Date1986-10-08
Product CodeJSJ
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

DRI-FORM: GBNA LISTERIA MEDIUM NO. M22300 is the device name listed in this FDA 510(k) record. The listed applicant is Gibco Laboratories Life Technologies, Inc.. It received FDA 510(k) clearance on 1986-10-08 under 510(k) number K863820. The device is classified under product code JSJ. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the DRI-FORM: GBNA LISTERIA MEDIUM NO. M22300?

DRI-FORM: GBNA LISTERIA MEDIUM NO. M22300 is a medical device that received FDA 510(k) clearance on 1986-10-08. The listed applicant is Gibco Laboratories Life Technologies, Inc.. The 510(k) number is K863820.

When did DRI-FORM: GBNA LISTERIA MEDIUM NO. M22300 receive FDA 510(k) clearance?

DRI-FORM: GBNA LISTERIA MEDIUM NO. M22300 received FDA 510(k) clearance on 1986-10-08, under 510(k) number K863820.

Who is the listed applicant for DRI-FORM: GBNA LISTERIA MEDIUM NO. M22300?

The FDA 510(k) record lists Gibco Laboratories Life Technologies, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for DRI-FORM: GBNA LISTERIA MEDIUM NO. M22300?

The FDA product code for DRI-FORM: GBNA LISTERIA MEDIUM NO. M22300 is JSJ.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Gibco Laboratories Life Technologies, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K871855SORBITOL MACCONKEY (SMAC) AGAR, DRI & PRE-FORMK871541MARTIN-LEWIS AGAR W/REDUCED VANCOMYCIN C0226K870134MCBRIDE LISTERIA AGAR W/CYCLOHEXIMIDE, DRI & PREK864755PSEUDOMONAS CEPACIA SELECTIVE AGAR, DRI & PRE-FORMK864014LOMBARD DOWELL AGAR BASEK863821MUELLER HINTON AGAR W/4%NACL AND OXACILLIN

View all 67 devices →

Related Devices (Code: JSJ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K882463POTATO DEXTROSE AGAR (PDA) - PRODUCT #P3421Lakewood Biochemical Co., Inc.K881544LITTMAN AGARAcumedia Manufacturers, Inc.K881561TERGITOL 7 BROTHAcumedia Manufacturers, Inc.K881526CHAPMAN STONE MEDIUMAcumedia Manufacturers, Inc.K881571YM BROTHAcumedia Manufacturers, Inc.K881578STREPTOSELAcumedia Manufacturers, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑